Crossmark

Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies

Crossref DOI link: https://doi.org/10.1007/s00702-024-02757-3

Published Online: 2024-03-30

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hilal, Fahd François https://orcid.org/0000-0002-1007-5925
Jeanblanc, Jerome https://orcid.org/0000-0003-0353-2777
Deschamps, Chloé https://orcid.org/0009-0008-0384-4344
Naassila, Mickael https://orcid.org/0000-0002-9788-0918
Pierrefiche, Olivier https://orcid.org/0000-0003-1427-9332
Ben Hamida, Sami https://orcid.org/0000-0001-9636-9432
License Information

Text and Data Mining valid from 2024-03-30

Version of Record valid from 2024-03-30
More Information

Article History

Received: 24 November 2023

Accepted: 22 February 2024

First Online: 30 March 2024